North Star Asset Management Inc Repligen Corp Transaction History

North Star Asset Management Inc

$2.15 Billion
Q4 2024

A detailed history of North Star Asset Management Inc transactions in Repligen Corp stock. As of the latest transaction made, North Star Asset Management Inc holds 90,127 shares of RGEN stock, worth $13.6 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares

90,127

Previous 92,130 2.17%

Holding current value

$13.6 Million

Previous $13.7 Million 5.38%

% of portfolio

0.6%

Previous 0.64%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 19, 2025	SELL	$123.41 - $160.92 $247,190 - $322,322	-2,003 Reduced 2.17%	90,127 $13 Million
Q3 2024 Nov 14, 2024	SELL	$119.79 - $167.35 $190,945 - $266,755	-1,594 Reduced 1.7%	92,130 $13.7 Million
Q2 2024 Aug 05, 2024	BUY	$120.0 - $182.95 $182,160 - $277,718	1,518 Added 1.65%	93,724 $11.8 Million
Q1 2024 May 08, 2024	BUY	$170.78 - $208.42 $93,929 - $114,631	550 Added 0.6%	92,206 $17 Million
Q4 2023 Feb 01, 2024	SELL	$114.17 - $185.35 $4,680 - $7,599	-41 Reduced 0.04%	91,656 $16.5 Million
Q3 2023 Oct 26, 2023	BUY	$138.78 - $176.51 $52,042 - $66,191	375 Added 0.41%	91,697 $14.6 Million
Q2 2023 Aug 09, 2023	BUY	$138.42 - $180.31 $321,964 - $419,401	2,326 Added 2.61%	91,322 $12.9 Million
Q1 2023 May 10, 2023	BUY	$154.26 - $198.1 $295,562 - $379,559	1,916 Added 2.2%	88,996 $15 Million
Q4 2022 Mar 06, 2023	BUY	$162.42 - $220.56 $413,196 - $561,104	2,544 Added 3.01%	87,080 $14.7 Million
Q3 2022 Nov 08, 2022	BUY	$160.42 - $256.21 $226,673 - $362,024	1,413 Added 1.7%	84,536 $15.8 Million
Q2 2022 Jul 28, 2022	BUY	$140.68 - $188.02 $61,195 - $81,788	435 Added 0.53%	83,123 $13.5 Million
Q1 2022 Apr 29, 2022	BUY	$161.19 - $257.96 $184,562 - $295,364	1,145 Added 1.4%	82,688 $15.6 Million
Q4 2021 Feb 07, 2022	SELL	$247.59 - $304.47 $494,684 - $608,331	-1,998 Reduced 2.39%	81,543 $21.6 Million
Q3 2021 Oct 20, 2021	SELL	$194.77 - $324.21 $1.18 Million - $1.97 Million	-6,082 Reduced 6.79%	83,541 $24.1 Million
Q2 2021 Jul 30, 2021	SELL	$165.87 - $220.95 $139,662 - $186,039	-842 Reduced 0.93%	89,623 $17.9 Million
Q1 2021 Apr 29, 2021	SELL	$180.37 - $226.26 $1.02 Million - $1.28 Million	-5,640 Reduced 5.87%	90,465 $17.6 Million
Q4 2020 Feb 16, 2021	SELL	$148.08 - $206.57 $389,154 - $542,865	-2,628 Reduced 2.66%	96,105 $18.4 Million
Q3 2020 Nov 02, 2020	SELL	$122.51 - $158.27 $1.01 Million - $1.31 Million	-8,272 Reduced 7.73%	98,733 $14.6 Million
Q2 2020 Jul 28, 2020	SELL	$94.33 - $140.48 $1.65 Million - $2.46 Million	-17,494 Reduced 14.05%	107,005 $13.2 Million
Q1 2020 Apr 24, 2020	SELL	$84.96 - $109.14 $498,715 - $640,651	-5,870 Reduced 4.5%	124,499 $12 Million
Q4 2019 Feb 06, 2020	SELL	$73.84 - $93.08 $275,866 - $347,746	-3,736 Reduced 2.79%	130,369 $12.1 Million
Q3 2019 Oct 25, 2019	SELL	$76.65 - $95.51 $754,925 - $940,677	-9,849 Reduced 6.84%	134,105 $10.3 Million
Q2 2019 Aug 12, 2019	SELL	$54.2 - $85.95 $191,326 - $303,403	-3,530 Reduced 2.39%	143,954 $12.4 Million
Q1 2019 Apr 26, 2019	BUY	$49.45 - $62.8 $105,823 - $134,392	2,140 Added 1.47%	147,484 $8.71 Million
Q4 2018 Jan 29, 2019	SELL	$48.26 - $68.88 $233,916 - $333,861	-4,847 Reduced 3.23%	145,344 $7.67 Million
Q3 2018 Oct 29, 2018	SELL	$46.8 - $58.97 $973,159 - $1.23 Million	-20,794 Reduced 12.16%	150,191 $8.33 Million
Q2 2018 Aug 10, 2018	SELL	$35.26 - $47.04 $10,225 - $13,641	-290 Reduced 0.17%	170,985 $8.04 Million
Q1 2018 Apr 27, 2018	BUY	$30.92 - $37.27 $1.91 Million - $2.3 Million	61,630 Added 56.21%	171,275 $6.2 Million
Q4 2017 Feb 01, 2018	BUY	$32.53 - $38.92 $2.75 Million - $3.29 Million	84,486 Added 335.81%	109,645 $3.98 Million
Q3 2017 Oct 25, 2017	BUY	$36.98 - $46.06 $356,856 - $444,479	9,650 Added 62.22%	25,159 $964,000
Q3 2017 Oct 25, 2017	SELL	$36.98 - $46.06 $186,379 - $232,142	-5,040 Reduced 24.53%	15,509 $546,000
Q2 2017 Aug 16, 2017	BUY	N/A	20,549	20,549 $852,000

Others Institutions Holding RGEN

# of Institutions

481

Shares Held

56.3M

Call Options Held

251K

Put Options Held

458K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.36B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of North Star Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on North Star Asset Management Inc with notifications on news.

Account

North Star Asset Management Inc Repligen Corp Transaction History